Irofin®(Deferiprone) - 500 mg
Deferiprone Lipomed contains the active substance deferiprone.
Share Now
| Name | Irofin® |
| Description | Deferiprone Lipomed contains the active substance deferiprone, which removes excess iron from the body; it is therefore called an iron chelating agent (ATC code: V03AC02). Deferiprone Lipomed is a cost-effective generic of deferiprone. The active substance is deferiprone (3-hydroxy-1,2-dimethylpyridin-4-one), a bidentate ligand which binds to iron in a 3:1 molar ratio. |
| Active Ingredient | Deferiprone |
| Indication | Deferiprone Lipomed monotherapy is indicated for the treatment of iron overload in patients with thalassaemia major when current chelation therapy is contraindicated or inadequate. |
| Strengths | 500 mg |
| Business Partner | Lipomed |
| Origin | Switzerland |
